FIELD: medicine.
SUBSTANCE: DNA is recovered from peripheral venous blood which is followed by a genetic typing of the APOE gene and detecting polymorphous alleles APOE*2, APOE*3, APOE*4; if the assays shows any genetic types containing alleles APOE*2, a high risk of endometrial cancer is predicted.
EFFECT: invention provides a highly specific criterion for predicting the risk of hyperproliferative diseases of the endometrium, including endometrioid adenocarcinoma in females with hyperplastic processes in the endometrium.
2 dwg, 10 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF HYPERPLASTIC PROCESSES OF ENDOMETRIUM | 2014 |
|
RU2557977C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF ENDOMETRIUM HYPERPLASIA IN WOMEN WITH GENITAL ENDOMETRIOSIS | 2011 |
|
RU2468367C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA IN WOMEN WITH NORMAL BODY WEIGHT | 2024 |
|
RU2834521C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA USING MOLECULAR GENETIC DATA | 2024 |
|
RU2834523C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA IN WOMEN WITH OVERWEIGHT OR OBESITY | 2024 |
|
RU2834146C1 |
| METHOD FOR PREDICTING RISK OF ENDOMETRIAL HYPERPLASTIC PROCESSES BASED ON GENETIC DATA | 2017 |
|
RU2650988C1 |
| METHOD FOR FORECASTING RISK OF DEVELOPMENT OF COMBINATION OF UTERINE FIBROID AND ENDOMETRIAL HYPERPLASTIC PROCESSES | 2018 |
|
RU2678970C1 |
| METHOD OF PREDICTING DEVELOPMENT OF RISK OF COMBINED PROLIFERATIVE REPRODUCTIVE SYSTEM DISEASES IN WOMEN | 2014 |
|
RU2557954C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING COMBINATION OF UTERINE FIBROIDS AND ADENOMYOSIS USING GENETIC DATA | 2018 |
|
RU2677866C1 |
| METHOD FOR PREDICTION OF DEVELOPING ENDOMETRIAL CANCER IN PATHOLOGICAL ENDOMETRIAL PROCESSES IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2466390C2 |
